An epileptic headache is a headache that occurs as the direct manifestation of a seizure, not merely alongside one. In these cases, the head pain itself is the seizure, driven by abnormal electrical discharges in the brain that happen to activate pain pathways rather than producing the convulsions or loss of awareness people typically associate with epilepsy. The condition is rare and frequently misdiagnosed as migraine or tension-type headache, partly because the pain has no unique clinical features that distinguish it at the bedside. Confirming the diagnosis requires catching the headache on an EEG and showing that the pain starts and stops in lockstep with epileptic brain activity.
What Makes a Headache “Epileptic”
Headaches crop up at every stage of a seizure. They can precede it, accompany it, or follow it. But the term “epileptic headache,” more precisely called ictal epileptic headache (IEH), refers specifically to a headache that is the seizure. More than 30 published case reports describe patients whose only seizure symptom was head pain, with no jerking, no staring spells, and no loss of consciousness.1PubMed. Epileptic headache: A rare form of painful seizure The pain can be throbbing, pressing, or stabbing, and it can appear on one side of the head or both. It may last minutes, hours, or occasionally days. None of these features help clinicians tell it apart from an ordinary headache, which is exactly why it flies under the radar so often.
A case report of a 23-year-old woman illustrates the problem well. She experienced severe headaches as her only symptom for an extended period, cycling through multiple treatments for presumed migraine before an EEG finally revealed epileptic discharges coinciding precisely with the pain. She responded to an anti-seizure medication, confirming the epileptic origin.2PubMed Central. Ictal Headache: A Case Report Stories like hers are scattered across the literature. The headache looks unremarkable. The clue that something else is going on tends to emerge only when standard headache treatments fail repeatedly, prompting a deeper workup.
Diagnosis Depends on Catching It in the Act
There is no blood test, no scan, and no questionnaire that can diagnose IEH on its own. The gold standard is an ictal EEG recording that captures epileptic discharges at the exact moment the headache begins and shows those discharges resolve when the headache ends. The diagnostic criteria require that the headache and EEG abnormalities both disappear promptly after an intravenous anti-seizure drug is given.3Epilepsy & Behavior. The International Classification of Headache Disorders 3rd edition (ICHD-3) and ictal epileptic headache That is a high bar, and it explains why confirmed cases remain so scarce.
Video-EEG monitoring, where patients are continuously recorded over hours or days, gives clinicians the best shot at catching these events. In one documented case, a 9-year-old girl had brief episodes of severe frontal headache that corresponded to spikes and slow waves beginning in the right temporal area. Brain imaging showed a developmental abnormality in that same region, and after surgery to remove it, her headaches disappeared entirely.4PubMed. Pure epileptic headache and related manifestations: a video-EEG report and discussion of terminology Another patient had frontal headaches linked on video-EEG to a discharge originating in the opposite temporal lobe, with MRI revealing hippocampal sclerosis on the same side as the electrical focus.5PubMed. Frontal headache in a patient with right temporal epilepsy: A video-EEG case report of ictal epileptic headache These cases show that the pain does not always line up neatly with the seizure focus in location, adding another layer of difficulty to clinical recognition.
The scarcity of confirmed diagnoses does not mean the condition itself is vanishingly rare. It more likely reflects how seldom EEGs are ordered for patients whose only complaint is headache. In a large survey of people with epilepsy, roughly a quarter reported headaches closely tied in time to their seizures, but only about 1 percent described pain occurring during the seizure itself as the dominant or sole symptom.6PubMed Central. Headache in epilepsy: prevalence and clinical features The true prevalence of isolated epileptic headache in the general population is simply unknown.
How Seizures Produce Head Pain
The brain itself cannot feel pain, so a seizure has to activate pain-sensitive structures outside the brain to cause a headache. Research in animal models shows that seizures fire up neurons in the trigeminovascular system, the network of nerve fibers that wraps around the blood vessels of the meninges (the membranes covering the brain). In one study, a seizure activated roughly half to two-thirds of different classes of these trigeminal neurons, with firing rates jumping two- to fourfold. The activation started anywhere from immediately to about 90 minutes after seizure onset and lasted anywhere from 10 minutes to 2 hours.7PubMed Central. Activation of Peripheral and Central Trigeminovascular Neurons by Seizure: Implications for Ictal and Postictal Headache When a local anesthetic was applied to the meninges to block those nerve endings, the headache-related neural activation was prevented even though the seizure itself continued. That result strongly suggests the pain originates from the periphery being recruited by central seizure activity, not from the seizure discharges alone.
A second mechanism linking seizures and headache involves cortical spreading depression (CSD), a slow wave of intense neuronal firing followed by a prolonged silencing of brain activity that sweeps across the cortex. CSD is the event thought to underlie migraine aura. In patients with acute brain injuries, researchers have recorded CSD waves that were time-locked to seizure activity, with the seizure apparently triggering the spreading depression in a majority of events.8PubMed Central. Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain Additional scalp-level recordings in epilepsy patients have detected slow-voltage shifts consistent with CSD preceding or accompanying seizures.9PubMed. Association of cortical spreading depression and seizures in patients with medically intractable epilepsy This crosstalk between seizure discharges and spreading depression may be one reason epilepsy and migraine so frequently travel together.
Neurochemistry adds another piece. CGRP (calcitonin gene-related peptide) is a molecule released by trigeminal nerve fibers during migraine attacks and is the target of an entire class of newer migraine drugs. An exploratory study measuring CGRP in tear fluid found that levels rose significantly after a seizure compared to between-seizure baselines, with a large effect size.10Seizure: European Journal of Epilepsy. Tear fluid CGRP changes in epilepsy – evidence from an exploratory pilot study The finding is preliminary and small, but it points toward the same pain-signaling molecule being involved in both seizure-related headache and migraine.
Shared Genetic and Molecular Ground Between Epilepsy and Migraine
People with epilepsy are significantly more likely to have migraine than the general population, and vice versa. Over 80 percent of people with epilepsy in one survey reported some form of headache.11Seizure. The burden of headache in people with epilepsy That overlap is not coincidence. Both conditions involve excessive neuronal excitability and share abnormalities in ion channels, the molecular gates that control how electrical signals move through nerve cells.12PubMed Central. Epilepsy and migraine-Are they comorbidity?
Whole-exome sequencing studies have begun to pin down the specific genes involved. In patients who have both migraine and epilepsy, researchers have found disease-relevant variants in ion channel genes such as SCN1A, KCNMA1, and KIF1A, as well as a structural gene called COL4A1. The variants affect sodium channels, potassium channels, and GABA receptors, all of which govern how easily neurons fire and how quickly they calm down.13PubMed. Uncovering common genetic risk factors in migraine and epilepsy through whole exome sequencing The implication is that some people inherit a nervous system wired to be susceptible to both conditions, and epileptic headache may sit right at the intersection.
Triggers That Overlap
The triggers that provoke seizures and the triggers that provoke migraine attacks are strikingly similar. A multicenter study of over 800 people with genetic or idiopathic epilepsy found that the top seizure triggers were stress (23%), sleep deprivation (22%), and fatigue (18%). Among those who also had migraine, the top headache triggers were stress (31%), sleep deprivation (28%), and noise (26%).14PubMed. Exploring shared triggers and potential etiopathogenesis between migraine and idiopathic/genetic epilepsy: Insights from a multicenter tertiary-based study The degree of overlap is hard to ignore: if you are someone prone to both, the same bad night of sleep or stressful week can lower your threshold for both a seizure and a headache, sometimes simultaneously.
Hormonal shifts deserve special attention. Catamenial epilepsy refers to a pattern in which seizures cluster around specific phases of the menstrual cycle. The mechanism involves the opposing effects of estrogen and progesterone on brain excitability: estrogen tends to increase it, while progesterone dials it down through its breakdown product, allopregnanolone, which enhances the brain’s main inhibitory system.15PubMed Central. Diagnosis and management of catamenial seizures: a review The premenstrual drop in progesterone and the mid-cycle surge of estrogen are both well-established migraine triggers as well. For women who have both epilepsy and migraine, these hormonal windows can become periods of compounded risk, making it harder to untangle whether a given headache episode is a seizure, a migraine, or one triggering the other.
The Migralepsy Controversy
“Migralepsy” is a term coined in 1960 to describe a situation in which a migraine aura triggers an epileptic seizure within an hour. The concept sounds tidy, but it has been a source of persistent controversy. The International Classification of Headache Disorders does include “migraine aura-triggered seizure” as a recognized complication of migraine, but the International League Against Epilepsy does not use the term in its own classification system at all.16PubMed. Migralepsy and related conditions: advances in pathophysiology and classification
The core concern is that many cases labeled as migralepsy were probably epileptic headaches misidentified as migraines. If headache is actually the opening salvo of a seizure rather than a migraine aura that happens to precede one, the clinical picture can look identical but the diagnosis is fundamentally different. Some researchers have argued the term should be retired entirely until unequivocal evidence of a true migraine-to-seizure sequence is produced. Others maintain that genuine cases do exist, though they are exceptionally rare, and that studying them could illuminate how spreading depression and seizure activity interact in the occipital lobe.17PubMed. Migralepsy, what it is and what it is not For anyone who has been told they have migralepsy, the practical takeaway is that the diagnosis warrants scrutiny and ideally an EEG to rule out ictal epileptic headache masquerading as migraine.
Post-Ictal Headache Is Far More Common
While ictal epileptic headache is rare, headache after a seizure is extremely common and often debilitating. About a fifth of people with epilepsy report post-ictal headaches, and the risk is higher in those who also have migraine between seizures, those on multiple anti-seizure medications, those with frequent seizures, and those whose seizures involve full-body convulsions.6PubMed Central. Headache in epilepsy: prevalence and clinical features These headaches can be severe and mimic migraine closely, with throbbing pain, nausea, and light sensitivity lasting hours. In occipital epilepsy, post-ictal headache is especially prominent, occurring in roughly two-thirds of patients even after brief visual seizures without convulsions.18Epileptic Disorders. Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine
Despite how common post-ictal headache is, the evidence for how to treat it is thin. A systematic review found that the available studies on post-ictal headache treatment provided a low level of evidence, though they suggested that sumatriptan (a standard migraine drug) and flunarizine (a calcium channel blocker) may offer some benefit.19PubMed. Treatment of postictal headache: a systematic review and future directions In practice, many clinicians reach for triptans or NSAIDs for post-ictal headache based on the assumption that the pain shares mechanisms with migraine, but rigorous trials are lacking.
Treatment When Headache Is the Seizure
When headache is confirmed as an ictal epileptic event, the treatment is anti-seizure medication, not painkillers. Standard migraine therapies address the downstream pain pathways but do nothing about the abnormal electrical activity driving them. In the case of the 23-year-old woman mentioned earlier, oxcarbazepine resolved her headaches because it stopped the underlying seizure discharges.2PubMed Central. Ictal Headache: A Case Report In the 9-year-old girl with a structural brain lesion, surgery to remove the abnormal tissue eliminated the headaches entirely.4PubMed. Pure epileptic headache and related manifestations: a video-EEG report and discussion of terminology
Some anti-seizure medications pull double duty. Valproate and topiramate are both established migraine preventives supported by Cochrane-level evidence, reducing migraine frequency by roughly one to two fewer attacks per month compared to placebo and more than doubling the chance of cutting migraine frequency in half.20PubMed. Anticonvulsants in migraine prophylaxis: a Cochrane review For a patient who has both epilepsy and frequent migraine, choosing one of these dual-purpose drugs can simplify the treatment regimen. Lamotrigine and gabapentin, on the other hand, did not outperform placebo for migraine prevention in the same review, so their usefulness is more limited to seizure control alone.
Vagus Nerve Stimulation and Other Non-Drug Approaches
Vagus nerve stimulation (VNS), a device-based therapy approved for drug-resistant epilepsy, has shown some promise for headache as well. In small case series, patients with implanted VNS devices who also had migraine reported reductions in headache frequency and intensity, with improvement appearing one to three months after the device was turned on.21PubMed. The effect of vagus nerve stimulation on migraines A separate report on patients with chronic, drug-resistant migraine and cluster headache found similar benefits.22PubMed. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches VNS is not a first-line headache treatment by any stretch, but for patients who already have the device for seizure control and who also suffer from headaches, the added benefit is worth knowing about.
Epileptic Headache in Children
Children present a unique diagnostic puzzle because headache in young kids is harder to characterize, and certain childhood epilepsy syndromes have prominent autonomic features that mimic other conditions entirely. Panayiotopoulos syndrome, a benign childhood epilepsy, produces seizures dominated by nausea, vomiting, pallor, and sometimes loss of consciousness, often during sleep. It frequently gets misdiagnosed as gastroenteritis, syncope, or migraine before the seizure nature is recognized.23Pediatrics. Panayiotopoulos Syndrome: A Benign Childhood Autonomic Epilepsy Frequently Imitating Encephalitis, Syncope, Migraine, Sleep Disorder, or Gastroenteritis Headache is not always the leading complaint in these children, but it can be part of the autonomic storm, and the broader lesson applies: seizures in kids can look nothing like what parents expect.
Treating headache-related comorbidities in pediatric epilepsy comes with an extra layer of caution. Historically, there has been worry that drugs used for headache or psychiatric conditions could lower the seizure threshold. More recent evidence suggests that most medications used for these comorbid conditions do not meaningfully increase seizure risk, though the data proving they actually work well for the comorbidities themselves in children with epilepsy remain limited.24PubMed Central. Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children Pediatric neurologists tend to favor anti-seizure drugs with known headache benefits, like valproate or topiramate, when both problems coexist.
The Burden Nobody Asks About
Headache in people with epilepsy is undertreated partly because it is under-asked-about. In a survey of 280 people with epilepsy, over 80 percent reported some form of headache. Among those with headaches occurring between seizures, about 40 percent had tension-type headache, about a third had migraine, and roughly 8 percent had headache from overuse of acute medications. The impact was substantial: over a third scored in the highest disability grade, meaning headache caused them to miss significant amounts of work or daily activity.11Seizure. The burden of headache in people with epilepsy Epilepsy clinic visits tend to focus on seizure frequency and medication side effects, with headache treated as a footnote. But for many patients, the headache is the symptom that most degrades their day-to-day life, and addressing it directly can meaningfully improve quality of life even when seizure control is already reasonable.
Medication-overuse headache deserves a specific mention here. People with epilepsy who take frequent acute pain relievers for their seizure-related or inter-ictal headaches can develop a rebound cycle where the painkillers themselves perpetuate daily or near-daily headache. The nearly 8 percent prevalence of medication-overuse headache in the survey above is a red flag that this phenomenon is not rare in this population. Recognizing it requires asking patients not only about their seizures but about how often they reach for over-the-counter pain medication, a question that often goes unasked in neurology appointments focused on epilepsy management.